News & Articles

A Queensland University of Technology collaborated resource merging scientific insight with practical laboratory methods

The kit as broad coverage for influenza strains, emerging SARS-CoV-2 variants, and detection of both RSV subgroups A and B

Collaboration between UpNano and Husun Technologies brings 2PP 3D-printing to one of the world’s largest technology markets

Acquisition to include Red One™ solid-phase cytometry platform for rapid sterility and bioburden testing, which expands Lonza’s portfolio of automated, scalable solutions for pharmaceutical quality control

Tuznue is a biosimilar of Herceptin (trastuzumab), developed to offer a more cost-effective therapeutic alternative for patients

New dengue antigen test delivers high clinical sensitivity and specificity, as well as inclusivity for all four dengue virus serotypes, helping clinicians distinguish dengue from other acute fever-causing illnesses

Collaboration will evaluate the impact of the OMED solution on the digestive health and quality of life of participants in a workplace setting

Activace platform enables targeted, genome-wide profiling of unmethylated DNA regions, providing a comprehensive view of the epigenome that can be scaled to the study of large patient cohorts

Researchers say the work demonstrates that precise gene editing can prevent infection by disrupting a pig protein the virus relies on to make copies of itself within the cells of the pig

Open-science research initiative, COVID Moonshot and the AI-driven Structure-enabled Antiviral Platform (ASAP) consortium, delivered a promising pre-clinical candidate

FDA clearance of MBT FAST™ Shuttle US IVD and MBT Compass HT CA software improves workflow efficiency and accelerates data processing and FDA approval of expanded reference library increases coverage to 549 validated microbial species

New facility expands the company’s capacity to meet the growing demand for comprehensive cell analysis solutions

Strategic alliance means a seamless, end‑to‑end ADC path — from cell line to commercial fill‑finish — under one coordinated platform

Dr. Werner Lanthaler will strengthen FairJourney Biologics’ global position as a highly efficient partner for antibody discovery and development

The knowledge could reduce the risk of severe bowel complications from radiotherapy, heralding a more personalized approach to prostate cancer treatment

Development agreement applies Optimer binders to cancer imaging and therapeutics

This tool will be launched as part of Roche’s new chronic kidney disease algorithm panel to support care across the stages of the disease which affects 700 million people globally

Combined portfolio unites Fluidic Sciences’ in‑solution microfluidic diffusional sizing technology with Sphere Bio’s proprietary picodroplet-microfluidic platforms, Cyto‑Mine Chroma, and high‑throughput assays – delivering end‑to‑end insight from cells to molecules

Swedish company, which speeds up prostate cancer diagnosis, chooses Milton Park for its first UK laboratory

Research grade recombinant protein expands toolkit of available CRISPR nucleases and increases efficiency of homology-directed repair (HDR) to enable more precise genome modifications